Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 8, 2014
Emerging opportunities for the combination of molecularly targeted drugs with radiotherapy
E J Searle, T M Illidge, I J Stratford
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 7, 2003
Cervical neuropathy following mantle radiotherapy
V J McFarlane, G P Clein, J Cole, et al.
Cell Biology International
|
August 31, 2000
Polyploid giant cells provide a survival mechanism for p53 mutant cells after DNA damage
T M Illidge, M S Cragg, B Fringes, et al.
Cell Biology International
|
August 31, 2000
Release of mitotic descendants by giant cells from irradiated Burkitt's lymphoma cell line
J A Erenpreisa, M S Cragg, B Fringes, et al.
The British Journal of Radiology
|
September 14, 2012
Radiotherapy physics research in the UK: challenges and proposed solutions
R I Mackay, N G Burnet, S Green, et al.
Blood
|
June 25, 1999
The importance of antibody-specificity in determining successful radioimmunotherapy of B-cell lymphoma
T M Illidge, M S Cragg, H M McBride, et al.
Leukemia
|
July 29, 2017
A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells
E J Cheadle, G Lipowska-Bhalla, S J Dovedi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2018
Recommendations for the clinical management of the elderly patient with malignant lymphoma
L Specht, B Aleman, H Eich, et al.
Leukemia
|
November 29, 2016
A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells
E J Cheadle, G Lipowska-Bhalla, S J Dovedi, et al.
Journal of Immunological Methods
|
June 16, 2010
Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects
G Hampson, T H Ward, J Cummings, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 8, 2014
Emerging opportunities for the combination of molecularly targeted drugs with radiotherapy
E J Searle, T M Illidge, I J Stratford
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 7, 2003
Cervical neuropathy following mantle radiotherapy
V J McFarlane, G P Clein, J Cole, et al.
Cell Biology International
|
August 31, 2000
Polyploid giant cells provide a survival mechanism for p53 mutant cells after DNA damage
T M Illidge, M S Cragg, B Fringes, et al.
Cell Biology International
|
August 31, 2000
Release of mitotic descendants by giant cells from irradiated Burkitt's lymphoma cell line
J A Erenpreisa, M S Cragg, B Fringes, et al.
The British Journal of Radiology
|
September 14, 2012
Radiotherapy physics research in the UK: challenges and proposed solutions
R I Mackay, N G Burnet, S Green, et al.
Blood
|
June 25, 1999
The importance of antibody-specificity in determining successful radioimmunotherapy of B-cell lymphoma
T M Illidge, M S Cragg, H M McBride, et al.
Leukemia
|
July 29, 2017
A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells
E J Cheadle, G Lipowska-Bhalla, S J Dovedi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2018
Recommendations for the clinical management of the elderly patient with malignant lymphoma
L Specht, B Aleman, H Eich, et al.
Leukemia
|
November 29, 2016
A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells
E J Cheadle, G Lipowska-Bhalla, S J Dovedi, et al.
Journal of Immunological Methods
|
June 16, 2010
Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects
G Hampson, T H Ward, J Cummings, et al.
Page
of 3